OP0220 Randomized, double-blind, global clinical trial to evaluate equivalence of CHS-1420 to adalimumab in patients with psoriasis and psoriatic arthritisJames R. O’Dell, Barbara Finck, Alan Kivitz et al.|Annals of the Rheumatic Diseases|2017Cited by 3
SAT0162 Switching from etanercept to CHS-0214: a one year, randomized, double-blind study in patients with rheumatoid arthritisJames R. O’Dell, Barbara Finck, Ingrid Louw et al.|Annals of the Rheumatic Diseases|2017Cited by 3